Status:
ACTIVE_NOT_RECRUITING
Integration of Hypertension Management Into HIV Care in Nigeria
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Human Immunodeficiency Virus
Hypertension
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study evaluates a tailored-practice facilitation (PF) strategy for integrating a task strengthening strategy for hypertension control (TASSH) for the care of patients living with HIV (PWH) within...
Detailed Description
Although access to antiretroviral therapy has led to increased survival among people living with HIV (PWH) in Africa, this population now has higher cardiovascular disease (CVD) - mortality than the g...
Eligibility Criteria
Inclusion
- Be an adult aged 18 years and older.
- Attends one of the 30 HIV clinics.
- Have a diagnosis of HTN with uncontrolled blood pressure, i.e. BP is 140-179/90-100 mm Hg.
- Ability to provide consent.
Exclusion
- BP\>180/110 mm Hg;
- history of chronic kidney disease, heart disease, diabetes or stroke, pregnancy
- Inability to provide informed consent.
- Refusal to participate in the study.
Key Trial Info
Start Date :
September 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2026
Estimated Enrollment :
830 Patients enrolled
Trial Details
Trial ID
NCT04704336
Start Date
September 13 2021
End Date
January 31 2026
Last Update
October 31 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Louis University (SLU)
St Louis, Missouri, United States, 63103
2
Nigerian Institute of Medical Research (NIMR)
Yaba, Lagos, Nigeria